HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCowen, K. C Articles by Bistrian, B. R Search for Related Content PubMed PubMed Citation Articles by McCowen, K. C Articles by Bistrian, B. R Agricola Articles by McCowen, K. C Articles by Bistrian, B. R

Immunonutrition: problematic or problem solving?^1,2,3

¹ From the Beth Israel Deaconess Medical Center and Harvard Medical School, Boston.

The addition of immune-modulating nutrients to enteral formulas has been examined in clinical trials and meta-analyses. Enhancing immunity through diet is generally done by adding n-3 fatty acids, arginine, and nucleotides to an otherwise nutritionally complete formula. Despite flaws in many studies, a consistent trend to reduced infectious complications has been seen with immunonutrition, especially in patients undergoing surgery for upper gastrointestinal cancer or trauma. In critical care populations, however, the results have been mixed. In this review, we analyze these studies and focus on select clinical points that may explain the variation. One common flaw has been a failure to deliver an adequate nutrition volume. Few patients, especially in the earliest studies, received even close to goal feeding. A minimum quantity of immunonutrition may be required for effective reduction in infections. When feeding volumes are low, immunonutrition is usually not better than an isonitrogenous control. In more recent studies, practitioners have been increasingly aggressive with enteral feeding, and this has been reflected in improved outcomes from immunonutrition. Early delivery of immunonutrition (preoperatively in surgical patients with cancer) might be particularly beneficial. Another consideration is illness severity: we discuss evidence that the use of immunonutrition in moderate illness is more likely to be helpful, whereas severe sepsis is probably beyond the reach of any nutritional intervention, and mild illness is more likely to improve irrespective of feeding. If future trials can consider these vital points, level 1 recommendations in favor of immunonutrition might be justified, although presently such evidence is lacking for most clinical indications.

Key Words: Immunonutrition • fish oil • arginine • nucleotides • enteral nutrition

This article has been cited by other articles:

				C. E. Kight Nutrition Considerations in Esophagectomy Patients Nutr Clin Pract, October 1, 2008; 23(5): 521 - 528. [Abstract] [Full Text] [PDF]

				S. M. Campbell An Anthology of Advances in Enteral Tube Feeding Formulations Nutr Clin Pract, August 1, 2006; 21(4): 411 - 415. [Abstract] [Full Text] [PDF]

				R. G. Martindale and G. Cresci Preventing Infectious Complications With Nutrition Intervention JPEN J Parenter Enteral Nutr, January 1, 2005; 29(1_suppl): S53 - S56. [Full Text] [PDF]

				M. S. Farber, J. Moses, and M. Korn Reducing Costs and Patient Morbidity in the Enterally Fed Intensive Care Unit Patient JPEN J Parenter Enteral Nutr, January 1, 2005; 29(1_suppl): S62 - S69. [Abstract] [Full Text] [PDF]

				V. Bansal, P. Rodriguez, G. Wu, D. C. Eichler, J. Zabaleta, F. Taheri, and J. B. Ochoa Citrulline Can Preserve Proliferation and Prevent the Loss of CD3 {zeta} Chain Under Conditions of Low Arginine JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 423 - 430. [Abstract] [Full Text] [PDF]

				P. C Calder Immunonutrition: Author's reply BMJ, September 20, 2003; 327(7416): 683 - 683. [Full Text]